Alexion Pharmaceuticals, Inc BD opportunity scan covering pipeline ownership, stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale using PatSnap MCP.

Celgene Corporation BD opportunity scan covering pipeline ownership, stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale using PatSnap MCP.

Cephalon, Inc BD opportunity scan covering pipeline ownership, stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale using PatSnap MCP.

Danaher Corporation BD opportunity scan covering pipeline ownership, stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale using PatSnap MCP.

NCT07707674 clinical trial report covering XNW-28012, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07714798 clinical trial report covering Universal STAR-T Cell(BriSTAR Immunotech), Phase 1, endpoints, sponsor, geography, readout timing and developmen

NCT07717086 clinical trial report covering HYR-PB21, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07719088 clinical trial report covering Psilocybin, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07615660 clinical trial report covering Bulumtatug fuvedotin, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.

NCT07612891 clinical trial report covering INV-6452, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.

NCT07615283 clinical trial report covering Zeprumetostat, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.

NCT07612787 clinical trial report covering ALK.CAR-T cells(University of Turin/Boston Children), Phase 1/2, endpoints, sponsor, geography, readout timing a